Advertisement

Index by author

July 01, 1993; Volume 266,Issue 1

A

  1. Abrahamsson, T

    1. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
      M Nordström, T Abrahamsson, M Ervik, E Forshult and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 147-152;

  2. Adams, M L

    1. Opioid-induced suppression of rat testicular function.
      M L Adams, B Sewing, J B Forman, E R Meyer and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 323-328;

  3. Aigner, T G

    1. MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs.
      H Ogura and T G Aigner
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 60-64;

  4. Andrioli, G C

    1. Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors.
      C Russo, M Marchi, G C Andrioli, P Cavazzani and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 142-146;

  5. Antonaccio, M J

    1. Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.
      M J Antonaccio, D Normandin, R Serafino and S Moreland
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 125-132;

  6. Aronstam, R S

    1. Role of prostanoids in the regulation of central cholinergic receptor sensitivity.
      J J Buccafusco, C A Lapp, R S Aronstam, A C Hays and L C Shuster
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 314-322;

  7. Audet, R

    1. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
      G Drapeau, R Audet, L Levesque, D Godin and F Marceau
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 192-199;

  8. Azzaro, A J

    1. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
      E A Johnson, C E Tsai, Y H Shahan and A J Azzaro
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 133-141;

B

  1. Bak, M

    1. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
      M Bak, M Shalmi, J S Petersen, L B Poulsen and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 33-40;

  2. Barbier, A J

    1. Involvement of the L-arginine: nitric oxide pathway in nonadrenergic noncholinergic relaxation of the cat gastric fundus.
      A J Barbier and R A Lefebvre
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 172-178;

  3. Baron, C B

    1. Common phosphatidylinositol 4,5-bisphosphate pools are involved in carbachol and serotonin activation of tracheal smooth muscle.
      C B Baron, J Pompeo, D Blackman and R F Coburn
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 8-15;

  4. Baverel, G

    1. Effect of valproate, sodium 2-propyl-4-pentenoate and sodium 2-propyl-2-pentenoate on renal substrate uptake and ammoniagenesis in the rat.
      M Elhamri, B Ferrier, M Martin and G Baverel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 89-96;

  5. Bean, J S

    1. Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
      R F Kauffman, J S Bean, W E Bloomquist and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 450-455;

  6. Berlan, M

    1. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
      J Galitzky, M Reverte, C Carpene, M Lafontan and M Berlan
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 358-366;

  7. Bertrand, C

    1. A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
      G Piedimonte, C Bertrand, P Geppetti, R M Snider, M C Desai and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 270-273;

  8. Billingham, M E

    1. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
      T A Deisher, H Narita, P Zera, R Ginsburg, M R Bristow, M E Billingham, M B Fowler and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 262-269;

  9. Billman, G E

    1. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation.
      G E Billman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 407-416;

  10. Blackman, D

    1. Common phosphatidylinositol 4,5-bisphosphate pools are involved in carbachol and serotonin activation of tracheal smooth muscle.
      C B Baron, J Pompeo, D Blackman and R F Coburn
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 8-15;

  11. Bloomquist, W E

    1. Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
      R F Kauffman, J S Bean, W E Bloomquist and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 450-455;

  12. Bristow, M R

    1. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
      T A Deisher, H Narita, P Zera, R Ginsburg, M R Bristow, M E Billingham, M B Fowler and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 262-269;

  13. Brooks, D P

    1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
      D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;

  14. Buccafusco, J J

    1. Role of prostanoids in the regulation of central cholinergic receptor sensitivity.
      J J Buccafusco, C A Lapp, R S Aronstam, A C Hays and L C Shuster
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 314-322;

  15. Bugnon, O

    1. Agonist-induced desensitization of dopamine D-1 receptors in bovine retina and rat striatum.
      S Ofori, O Bugnon and M Schorderet
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 350-357;

C

  1. Carpene, C

    1. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
      J Galitzky, M Reverte, C Carpene, M Lafontan and M Berlan
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 358-366;

  2. Carpentier, R G

    1. Cocaine enhances postrest and paired-stimulation potentiation in rat papillary muscle.
      R G Carpentier, B R Coleman and D J Patel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 41-46;

  3. Carruba, M O

    1. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
      E Nisoli, C Tonello, R Imhof, R Scherschlicht, M da Prada and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 97-105;

  4. Cavazzani, P

    1. Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors.
      C Russo, M Marchi, G C Andrioli, P Cavazzani and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 142-146;

  5. Chakder, S

    1. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
      S Chakder and S Rattan
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 392-399;

  6. Chan, C F

    1. Acetylpolyamines decrease blood pressure, [Ca++]i and isometric force of vascular smooth muscle.
      L Y Wing, C F Chan and M J Jiang
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 179-183;

  7. Chang, E B

    1. Sodium nitroprusside stimulates anion secretion and inhibits sodium chloride absorption in rat colon.
      K T Wilson, Y Xie, M W Musch and E B Chang
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 224-230;

  8. Chen, S Y

    1. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine.
      B A Sorg, S Y Chen and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 424-430;

  9. Chiba, K

    1. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
      K Chiba, K Kobayashi, K Manabe, M Tani, T Kamataki and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 52-59;

  10. Chotinaruemol, S

    1. Guinea pig ileitis is attenuated by the leumedin N-(fluorenyl-9- methoxycarbonyl)-leucine (NPC 15199).
      M J Miller, S Chotinaruemol, H Sadowska-Krowikca, X J Zhang, J A McIntyre and D A Clark
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 468-472;

  11. Choudhuri, S

    1. Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
      Y Liu, H Kreppel, J Liu, S Choudhuri and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 400-406;

  12. Christensen, S

    1. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
      M Bak, M Shalmi, J S Petersen, L B Poulsen and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 33-40;

  13. Churchill, P

    1. The baroreceptor mechanism for controlling renin secretion: effect of calcium channel blockers.
      T Jones-Dombi and P Churchill
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 274-278;

  14. Churchill, P C

    1. Purinergic P2y receptors stimulate renin secretion by rat renal cortical slices.
      P C Churchill and V R Ellis
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 160-163;

  15. Cicero, T J

    1. Opioid-induced suppression of rat testicular function.
      M L Adams, B Sewing, J B Forman, E R Meyer and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 323-328;

  16. Clark, D A

    1. Guinea pig ileitis is attenuated by the leumedin N-(fluorenyl-9- methoxycarbonyl)-leucine (NPC 15199).
      M J Miller, S Chotinaruemol, H Sadowska-Krowikca, X J Zhang, J A McIntyre and D A Clark
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 468-472;

  17. Clark, J A

    1. Modulation of Mu1 opioid binding by magnesium: evidence for multiple receptor conformations.
      K M Standifer, J A Clark and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 106-113;

  18. Coburn, R F

    1. Common phosphatidylinositol 4,5-bisphosphate pools are involved in carbachol and serotonin activation of tracheal smooth muscle.
      C B Baron, J Pompeo, D Blackman and R F Coburn
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 8-15;

  19. Cohen, M L

    1. Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
      R F Kauffman, J S Bean, W E Bloomquist and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 450-455;

  20. Coleman, B R

    1. Cocaine enhances postrest and paired-stimulation potentiation in rat papillary muscle.
      R G Carpentier, B R Coleman and D J Patel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 41-46;

  21. Cook, C S

    1. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
      C S Cook, C Hauswald, J A Oppermann and G L Schoenhard
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 1-7;

  22. Cormann, P

    1. Electrogenic and electroneutral HCO3-secretion by guinea pig gallbladder epithelium: discriminatory abilities of Cl- channel blockers.
      K U Petersen, P Cormann, H J Macherey, G Sprakties and J M Winterhager
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 65-73;

  23. Cotman, C W

    1. L-2-amino-4-phosphonobutanoic acid and 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid reduce paired-pulse depression recorded from medial perforant path in the dentate gyrus of rat hippocampal slices.
      J S Kahle and C W Cotman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 207-215;

D

  1. da Prada, M

    1. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
      E Nisoli, C Tonello, R Imhof, R Scherschlicht, M da Prada and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 97-105;

  2. Davis, B B

    1. Phenylbutazone peroxidatic metabolism and conjugation.
      V M Lakshmi, T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 81-88;

  3. Deisher, T A

    1. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
      T A Deisher, H Narita, P Zera, R Ginsburg, M R Bristow, M E Billingham, M B Fowler and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 262-269;

  4. Demontis, G C

    1. Enhancement of gamma-aminobutyric acidA receptor function and binding by the volatile anesthetic halothane.
      B Longoni, G C Demontis and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 153-159;

  5. DePalma, P D

    1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
      D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;

  6. Desai, M C

    1. A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
      G Piedimonte, C Bertrand, P Geppetti, R M Snider, M C Desai and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 270-273;

  7. Dondio, G

    1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
      D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;

  8. Drapeau, G

    1. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
      G Drapeau, R Audet, L Levesque, D Godin and F Marceau
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 192-199;

  9. Drescher, U

    1. Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
      F Knoflach, U Drescher, L Scheurer, P Malherbe and H Mohler
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 385-391;

E

  1. Edwards, R M

    1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
      D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;

  2. Ehlert, F J

    1. Kinetics of activation and in vivo muscarinic receptor binding of N-(2-bromoethyl)-4-piperidinyl diphenylacetate: an analog of 4-DAMP mustard.
      M T Griffin, E A Thomas and F J Ehlert
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 301-305;

  3. Eisenhofer, G

    1. Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
      J W Lenders, R Kvetnansky, K Pacak, D S Goldstein, I J Kopin and G Eisenhofer
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 288-293;

  4. Ekblom, M

    1. Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats.
      M Ekblom, M Hammarlund-Udenaes and L Paalzow
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 244-252;

  5. el-Fakahany, E E

    1. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
      S Z Wang and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 237-243;

  6. Elhamri, M

    1. Effect of valproate, sodium 2-propyl-4-pentenoate and sodium 2-propyl-2-pentenoate on renal substrate uptake and ammoniagenesis in the rat.
      M Elhamri, B Ferrier, M Martin and G Baverel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 89-96;

  7. Ellis, V R

    1. Purinergic P2y receptors stimulate renin secretion by rat renal cortical slices.
      P C Churchill and V R Ellis
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 160-163;

  8. Ervik, M

    1. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
      M Nordström, T Abrahamsson, M Ervik, E Forshult and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 147-152;

F

  1. Ferrier, B

    1. Effect of valproate, sodium 2-propyl-4-pentenoate and sodium 2-propyl-2-pentenoate on renal substrate uptake and ammoniagenesis in the rat.
      M Elhamri, B Ferrier, M Martin and G Baverel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 89-96;

  2. Findlay, I

    1. Sulphonylurea drugs no longer inhibit ATP-sensitive K+ channels during metabolic stress in cardiac muscle.
      I Findlay
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 456-467;

  3. Forman, J B

    1. Opioid-induced suppression of rat testicular function.
      M L Adams, B Sewing, J B Forman, E R Meyer and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 323-328;

  4. Forshult, E

    1. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
      M Nordström, T Abrahamsson, M Ervik, E Forshult and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 147-152;

  5. Fowler, M B

    1. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
      T A Deisher, H Narita, P Zera, R Ginsburg, M R Bristow, M E Billingham, M B Fowler and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 262-269;

  6. Fuchs, B A

    1. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: involvement of both opiate and glucocorticoid receptors.
      B A Fuchs and S B Pruett
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 417-423;

G

  1. Galitzky, J

    1. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
      J Galitzky, M Reverte, C Carpene, M Lafontan and M Berlan
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 358-366;

  2. Garg, L C

    1. Alpha-2 adrenoceptors in medullary thick ascending limbs of the rabbit kidney.
      D Mohuczy-Dominiak and L C Garg
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 279-287;

  3. Gellai, M

    1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
      D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;

  4. Geppetti, P

    1. A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
      G Piedimonte, C Bertrand, P Geppetti, R M Snider, M C Desai and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 270-273;

  5. Giardina, G

    1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
      D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;

  6. Ginsburg, R

    1. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
      T A Deisher, H Narita, P Zera, R Ginsburg, M R Bristow, M E Billingham, M B Fowler and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 262-269;

  7. Glauser, T A

    1. Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.
      T A Glauser, A N Nelson, D E Zembower, J J Lipsky and R M Weinshilboum
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 23-32;

  8. Glavin, G B

    1. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
      S B Penner, D D Smyth and G B Glavin
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 339-343;

  9. Godin, D

    1. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
      G Drapeau, R Audet, L Levesque, D Godin and F Marceau
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 192-199;

  10. Goldstein, D S

    1. Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
      J W Lenders, R Kvetnansky, K Pacak, D S Goldstein, I J Kopin and G Eisenhofer
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 288-293;

  11. Griffin, M T

    1. Kinetics of activation and in vivo muscarinic receptor binding of N-(2-bromoethyl)-4-piperidinyl diphenylacetate: an analog of 4-DAMP mustard.
      M T Griffin, E A Thomas and F J Ehlert
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 301-305;

  12. Gupta, R C

    1. Comparison of adenosine and muscarinic receptor-mediated effects on protein phosphatase inhibitor-1 activity in the heart.
      R C Gupta, J Neumann and A M Watanabe
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 16-22;

H

  1. Hammarlund-Udenaes, M

    1. Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats.
      M Ekblom, M Hammarlund-Udenaes and L Paalzow
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 244-252;

  2. Hand, J M

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

  3. Hauswald, C

    1. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
      C S Cook, C Hauswald, J A Oppermann and G L Schoenhard
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 1-7;

  4. Hays, A C

    1. Role of prostanoids in the regulation of central cholinergic receptor sensitivity.
      J J Buccafusco, C A Lapp, R S Aronstam, A C Hays and L C Shuster
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 314-322;

  5. Hitzemann, B

    1. Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice.
      R Hitzemann, Y Qian and B Hitzemann
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 431-438;

  6. Hitzemann, R

    1. Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice.
      R Hitzemann, Y Qian and B Hitzemann
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 431-438;

  7. Hoffman, B B

    1. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
      T A Deisher, H Narita, P Zera, R Ginsburg, M R Bristow, M E Billingham, M B Fowler and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 262-269;

I

  1. Imhof, R

    1. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
      E Nisoli, C Tonello, R Imhof, R Scherschlicht, M da Prada and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 97-105;

  2. Inada, Y

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  3. Ishine, T

    1. Ca(++)-independent relaxation mediated by beta adrenoceptor in Ca(++)-independent contraction of uterine smooth muscle.
      T Ishine, Y Miyauchi and M K Uchida
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 367-373;

  4. Ishizaki, T

    1. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
      K Chiba, K Kobayashi, K Manabe, M Tani, T Kamataki and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 52-59;

  5. Iwamoto, E T

    1. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
      E T Iwamoto and L Marion
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 329-338;

J

  1. Jiang, M J

    1. Acetylpolyamines decrease blood pressure, [Ca++]i and isometric force of vascular smooth muscle.
      L Y Wing, C F Chan and M J Jiang
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 179-183;

  2. Johnson, E A

    1. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
      E A Johnson, C E Tsai, Y H Shahan and A J Azzaro
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 133-141;

  3. Jones-Dombi, T

    1. The baroreceptor mechanism for controlling renin secretion: effect of calcium channel blockers.
      T Jones-Dombi and P Churchill
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 274-278;

  4. Jugus, M

    1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
      D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;

K

  1. Kadowaki, M

    1. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
      M Kadowaki, Y Nagakura, M Tomoi, J Mori and M Kohsaka
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 74-80;

  2. Kahle, J S

    1. L-2-amino-4-phosphonobutanoic acid and 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid reduce paired-pulse depression recorded from medial perforant path in the dentate gyrus of rat hippocampal slices.
      J S Kahle and C W Cotman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 207-215;

  3. Kalivas, P W

    1. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine.
      B A Sorg, S Y Chen and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 424-430;

  4. Kamataki, T

    1. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
      K Chiba, K Kobayashi, K Manabe, M Tani, T Kamataki and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 52-59;

  5. Kanayama, T

    1. A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.
      T Kanayama, Y Kimura and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 344-349;

  6. Karasawa, A

    1. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
      H Mizumoto, A Karasawa and K Kubo
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 200-206;

  7. Kauffman, R F

    1. Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
      R F Kauffman, J S Bean, W E Bloomquist and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 450-455;

  8. Kimura, Y

    1. A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.
      T Kanayama, Y Kimura and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 344-349;

  9. Klaassen, C D

    1. Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
      Y Liu, H Kreppel, J Liu, S Choudhuri and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 400-406;

  10. Knoflach, F

    1. Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
      F Knoflach, U Drescher, L Scheurer, P Malherbe and H Mohler
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 385-391;

  11. Kobayashi, K

    1. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
      K Chiba, K Kobayashi, K Manabe, M Tani, T Kamataki and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 52-59;

  12. Kohara, Y

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  13. Kohsaka, M

    1. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
      M Kadowaki, Y Nagakura, M Tomoi, J Mori and M Kohsaka
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 74-80;

  14. Kopin, I J

    1. Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
      J W Lenders, R Kvetnansky, K Pacak, D S Goldstein, I J Kopin and G Eisenhofer
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 288-293;

  15. Kramer, R E

    1. Effects of diltiazem on calcium metabolism in cultured bovine glomerulosa cells: relationships to the actions of angiotensin II and potassium.
      R E Kramer
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 374-384;

  16. Kreppel, H

    1. Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
      Y Liu, H Kreppel, J Liu, S Choudhuri and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 400-406;

  17. Kubo, K

    1. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
      H Mizumoto, A Karasawa and K Kubo
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 200-206;
    2. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  18. Kvetnansky, R

    1. Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
      J W Lenders, R Kvetnansky, K Pacak, D S Goldstein, I J Kopin and G Eisenhofer
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 288-293;

L

  1. Lafontan, M

    1. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
      J Galitzky, M Reverte, C Carpene, M Lafontan and M Berlan
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 358-366;

  2. Lakshmi, V M

    1. Phenylbutazone peroxidatic metabolism and conjugation.
      V M Lakshmi, T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 81-88;

  3. Lapp, C A

    1. Role of prostanoids in the regulation of central cholinergic receptor sensitivity.
      J J Buccafusco, C A Lapp, R S Aronstam, A C Hays and L C Shuster
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 314-322;

  4. Lee, N M

    1. Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.
      A E Takemori, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 121-124;

  5. Lefebvre, R A

    1. Involvement of the L-arginine: nitric oxide pathway in nonadrenergic noncholinergic relaxation of the cat gastric fundus.
      A J Barbier and R A Lefebvre
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 172-178;

  6. Legrand, C

    1. Heterogeneity of alpha-2 adrenoceptors in pregnant rat uterus: identification of subtypes and autoradiographic distribution.
      C Legrand, S Mhaouty, C Rigolot and J P Maltier
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 439-449;

  7. Lenders, J W

    1. Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
      J W Lenders, R Kvetnansky, K Pacak, D S Goldstein, I J Kopin and G Eisenhofer
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 288-293;

  8. Levesque, L

    1. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
      G Drapeau, R Audet, L Levesque, D Godin and F Marceau
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 192-199;

  9. Lipsky, J J

    1. Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.
      T A Glauser, A N Nelson, D E Zembower, J J Lipsky and R M Weinshilboum
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 23-32;

  10. Liu, J

    1. Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
      Y Liu, H Kreppel, J Liu, S Choudhuri and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 400-406;

  11. Liu, Y

    1. Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
      Y Liu, H Kreppel, J Liu, S Choudhuri and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 400-406;

  12. Loh, H H

    1. Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.
      A E Takemori, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 121-124;

  13. Longoni, B

    1. Enhancement of gamma-aminobutyric acidA receptor function and binding by the volatile anesthetic halothane.
      B Longoni, G C Demontis and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 153-159;

  14. Löscher, W

    1. Anticonvulsant efficacy and adverse effects of phenytoin during chronic treatment in amygdala-kindled rats.
      C Rundfeldt and W Löscher
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 216-223;

M

  1. Macherey, H J

    1. Electrogenic and electroneutral HCO3-secretion by guinea pig gallbladder epithelium: discriminatory abilities of Cl- channel blockers.
      K U Petersen, P Cormann, H J Macherey, G Sprakties and J M Winterhager
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 65-73;

  2. Malherbe, P

    1. Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
      F Knoflach, U Drescher, L Scheurer, P Malherbe and H Mohler
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 385-391;

  3. Maltier, J P

    1. Heterogeneity of alpha-2 adrenoceptors in pregnant rat uterus: identification of subtypes and autoradiographic distribution.
      C Legrand, S Mhaouty, C Rigolot and J P Maltier
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 439-449;

  4. Manabe, K

    1. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
      K Chiba, K Kobayashi, K Manabe, M Tani, T Kamataki and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 52-59;

  5. Marala, R B

    1. Direct evidence for the coupling of A2-adenosine receptor to stimulatory guanine nucleotide-binding-protein in bovine brain striatum.
      R B Marala and S J Mustafa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 294-300;

  6. Marceau, F

    1. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
      G Drapeau, R Audet, L Levesque, D Godin and F Marceau
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 192-199;

  7. Marchi, M

    1. Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors.
      C Russo, M Marchi, G C Andrioli, P Cavazzani and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 142-146;

  8. Marion, L

    1. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
      E T Iwamoto and L Marion
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 329-338;

  9. Martin, M

    1. Effect of valproate, sodium 2-propyl-4-pentenoate and sodium 2-propyl-2-pentenoate on renal substrate uptake and ammoniagenesis in the rat.
      M Elhamri, B Ferrier, M Martin and G Baverel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 89-96;

  10. Mattammal, M B

    1. Phenylbutazone peroxidatic metabolism and conjugation.
      V M Lakshmi, T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 81-88;

  11. Matthews, J K

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

  12. Mayeux, P R

    1. Intracellular calcium mediates the cytotoxicity of lipid A in LLC-PK1 cells.
      P R Mayeux and S V Shah
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 47-51;

  13. McIntyre, J A

    1. Guinea pig ileitis is attenuated by the leumedin N-(fluorenyl-9- methoxycarbonyl)-leucine (NPC 15199).
      M J Miller, S Chotinaruemol, H Sadowska-Krowikca, X J Zhang, J A McIntyre and D A Clark
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 468-472;

  14. Meyer, E R

    1. Opioid-induced suppression of rat testicular function.
      M L Adams, B Sewing, J B Forman, E R Meyer and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 323-328;

  15. Mhaouty, S

    1. Heterogeneity of alpha-2 adrenoceptors in pregnant rat uterus: identification of subtypes and autoradiographic distribution.
      C Legrand, S Mhaouty, C Rigolot and J P Maltier
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 439-449;

  16. Miller, M J

    1. Guinea pig ileitis is attenuated by the leumedin N-(fluorenyl-9- methoxycarbonyl)-leucine (NPC 15199).
      M J Miller, S Chotinaruemol, H Sadowska-Krowikca, X J Zhang, J A McIntyre and D A Clark
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 468-472;

  17. Misiano, P

    1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
      D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;

  18. Miyauchi, Y

    1. Ca(++)-independent relaxation mediated by beta adrenoceptor in Ca(++)-independent contraction of uterine smooth muscle.
      T Ishine, Y Miyauchi and M K Uchida
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 367-373;

  19. Mizogami, S

    1. A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.
      T Kanayama, Y Kimura and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 344-349;

  20. Mizumoto, H

    1. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
      H Mizumoto, A Karasawa and K Kubo
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 200-206;

  21. Mohler, H

    1. Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
      F Knoflach, U Drescher, L Scheurer, P Malherbe and H Mohler
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 385-391;

  22. Mohuczy-Dominiak, D

    1. Alpha-2 adrenoceptors in medullary thick ascending limbs of the rabbit kidney.
      D Mohuczy-Dominiak and L C Garg
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 279-287;

  23. Moreland, S

    1. Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.
      M J Antonaccio, D Normandin, R Serafino and S Moreland
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 125-132;

  24. Mori, J

    1. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
      M Kadowaki, Y Nagakura, M Tomoi, J Mori and M Kohsaka
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 74-80;

  25. Musch, M W

    1. Sodium nitroprusside stimulates anion secretion and inhibits sodium chloride absorption in rat colon.
      K T Wilson, Y Xie, M W Musch and E B Chang
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 224-230;

  26. Mustafa, S J

    1. Direct evidence for the coupling of A2-adenosine receptor to stimulatory guanine nucleotide-binding-protein in bovine brain striatum.
      R B Marala and S J Mustafa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 294-300;

N

  1. Nadel, J A

    1. A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
      G Piedimonte, C Bertrand, P Geppetti, R M Snider, M C Desai and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 270-273;

  2. Nagakura, Y

    1. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
      M Kadowaki, Y Nagakura, M Tomoi, J Mori and M Kohsaka
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 74-80;

  3. Naka, T

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  4. Narita, H

    1. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
      T A Deisher, H Narita, P Zera, R Ginsburg, M R Bristow, M E Billingham, M B Fowler and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 262-269;

  5. Nelson, A N

    1. Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.
      T A Glauser, A N Nelson, D E Zembower, J J Lipsky and R M Weinshilboum
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 23-32;

  6. Neumann, J

    1. Comparison of adenosine and muscarinic receptor-mediated effects on protein phosphatase inhibitor-1 activity in the heart.
      R C Gupta, J Neumann and A M Watanabe
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 16-22;

  7. Newsholme, S J

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

  8. Nishikawa, K

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  9. Nisoli, E

    1. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
      E Nisoli, C Tonello, R Imhof, R Scherschlicht, M da Prada and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 97-105;

  10. Noda, M

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  11. Nordström, M

    1. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
      M Nordström, T Abrahamsson, M Ervik, E Forshult and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 147-152;

  12. Normandin, D

    1. Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.
      M J Antonaccio, D Normandin, R Serafino and S Moreland
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 125-132;

  13. Novak, L B

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

O

  1. Ofori, S

    1. Agonist-induced desensitization of dopamine D-1 receptors in bovine retina and rat striatum.
      S Ofori, O Bugnon and M Schorderet
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 350-357;

  2. Ogura, H

    1. MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs.
      H Ogura and T G Aigner
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 60-64;

  3. Ojima, M

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  4. Olsen, R W

    1. Enhancement of gamma-aminobutyric acidA receptor function and binding by the volatile anesthetic halothane.
      B Longoni, G C Demontis and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 153-159;

  5. Oppermann, J A

    1. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
      C S Cook, C Hauswald, J A Oppermann and G L Schoenhard
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 1-7;

  6. Osborn, R R

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

P

  1. Paalzow, L

    1. Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats.
      M Ekblom, M Hammarlund-Udenaes and L Paalzow
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 244-252;

  2. Pacak, K

    1. Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
      J W Lenders, R Kvetnansky, K Pacak, D S Goldstein, I J Kopin and G Eisenhofer
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 288-293;

  3. Pasternak, G W

    1. Modulation of Mu1 opioid binding by magnesium: evidence for multiple receptor conformations.
      K M Standifer, J A Clark and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 106-113;

  4. Patel, D J

    1. Cocaine enhances postrest and paired-stimulation potentiation in rat papillary muscle.
      R G Carpentier, B R Coleman and D J Patel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 41-46;

  5. Penner, S B

    1. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
      S B Penner, D D Smyth and G B Glavin
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 339-343;

  6. Petersen, J S

    1. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
      M Bak, M Shalmi, J S Petersen, L B Poulsen and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 33-40;

  7. Petersen, K U

    1. Electrogenic and electroneutral HCO3-secretion by guinea pig gallbladder epithelium: discriminatory abilities of Cl- channel blockers.
      K U Petersen, P Cormann, H J Macherey, G Sprakties and J M Winterhager
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 65-73;

  8. Petrone, G

    1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
      D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;

  9. Piedimonte, G

    1. A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
      G Piedimonte, C Bertrand, P Geppetti, R M Snider, M C Desai and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 270-273;

  10. Pompeo, J

    1. Common phosphatidylinositol 4,5-bisphosphate pools are involved in carbachol and serotonin activation of tracheal smooth muscle.
      C B Baron, J Pompeo, D Blackman and R F Coburn
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 8-15;

  11. Poulsen, L B

    1. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
      M Bak, M Shalmi, J S Petersen, L B Poulsen and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 33-40;

  12. Pruett, S B

    1. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: involvement of both opiate and glucocorticoid receptors.
      B A Fuchs and S B Pruett
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 417-423;

Q

  1. Qian, Y

    1. Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice.
      R Hitzemann, Y Qian and B Hitzemann
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 431-438;

R

  1. Raiteri, M

    1. Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors.
      C Russo, M Marchi, G C Andrioli, P Cavazzani and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 142-146;

  2. Rattan, S

    1. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
      S Chakder and S Rattan
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 392-399;

  3. Regårdh, C G

    1. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
      M Nordström, T Abrahamsson, M Ervik, E Forshult and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 147-152;

  4. Reverte, M

    1. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
      J Galitzky, M Reverte, C Carpene, M Lafontan and M Berlan
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 358-366;

  5. Rigolot, C

    1. Heterogeneity of alpha-2 adrenoceptors in pregnant rat uterus: identification of subtypes and autoradiographic distribution.
      C Legrand, S Mhaouty, C Rigolot and J P Maltier
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 439-449;

  6. Rosenbaum, J S

    1. The mechanism for the rapid desensitization in bradykinin-stimulated inositol monophosphate production in NG108-15 cells involves interaction of a single receptor with multiple signaling pathways.
      D H Wolsing and J S Rosenbaum
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 253-261;

  7. Rundfeldt, C

    1. Anticonvulsant efficacy and adverse effects of phenytoin during chronic treatment in amygdala-kindled rats.
      C Rundfeldt and W Löscher
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 216-223;

  8. Russo, C

    1. Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors.
      C Russo, M Marchi, G C Andrioli, P Cavazzani and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 142-146;

S

  1. Sadowska-Krowikca, H

    1. Guinea pig ileitis is attenuated by the leumedin N-(fluorenyl-9- methoxycarbonyl)-leucine (NPC 15199).
      M J Miller, S Chotinaruemol, H Sadowska-Krowikca, X J Zhang, J A McIntyre and D A Clark
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 468-472;

  2. Sanada, T

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  3. Sbacchi, M

    1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
      D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;

  4. Scherschlicht, R

    1. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
      E Nisoli, C Tonello, R Imhof, R Scherschlicht, M da Prada and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 97-105;

  5. Scheurer, L

    1. Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
      F Knoflach, U Drescher, L Scheurer, P Malherbe and H Mohler
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 385-391;

  6. Schoenhard, G L

    1. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
      C S Cook, C Hauswald, J A Oppermann and G L Schoenhard
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 1-7;

  7. Schorderet, M

    1. Agonist-induced desensitization of dopamine D-1 receptors in bovine retina and rat striatum.
      S Ofori, O Bugnon and M Schorderet
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 350-357;

  8. Serafino, R

    1. Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.
      M J Antonaccio, D Normandin, R Serafino and S Moreland
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 125-132;

  9. Sewing, B

    1. Opioid-induced suppression of rat testicular function.
      M L Adams, B Sewing, J B Forman, E R Meyer and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 323-328;

  10. Shah, S V

    1. Intracellular calcium mediates the cytotoxicity of lipid A in LLC-PK1 cells.
      P R Mayeux and S V Shah
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 47-51;

  11. Shahan, Y H

    1. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
      E A Johnson, C E Tsai, Y H Shahan and A J Azzaro
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 133-141;

  12. Shalmi, M

    1. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
      M Bak, M Shalmi, J S Petersen, L B Poulsen and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 33-40;

  13. Shibouta, Y

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  14. Shuster, L C

    1. Role of prostanoids in the regulation of central cholinergic receptor sensitivity.
      J J Buccafusco, C A Lapp, R S Aronstam, A C Hays and L C Shuster
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 314-322;

  15. Slavik, K J

    1. Naloxone-induced potentiation of cardiac alpha-2 adrenoceptor-mediated depression of neurogenic tachycardia.
      K J Slavik and J E Szilagyi
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 184-191;

  16. Smyth, D D

    1. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
      S B Penner, D D Smyth and G B Glavin
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 339-343;

  17. Snider, R M

    1. A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
      G Piedimonte, C Bertrand, P Geppetti, R M Snider, M C Desai and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 270-273;

  18. Sorg, B A

    1. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine.
      B A Sorg, S Y Chen and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 424-430;

  19. Sprakties, G

    1. Electrogenic and electroneutral HCO3-secretion by guinea pig gallbladder epithelium: discriminatory abilities of Cl- channel blockers.
      K U Petersen, P Cormann, H J Macherey, G Sprakties and J M Winterhager
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 65-73;

  20. Standifer, K M

    1. Modulation of Mu1 opioid binding by magnesium: evidence for multiple receptor conformations.
      K M Standifer, J A Clark and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 106-113;

  21. Szilagyi, J E

    1. Naloxone-induced potentiation of cardiac alpha-2 adrenoceptor-mediated depression of neurogenic tachycardia.
      K J Slavik and J E Szilagyi
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 184-191;

T

  1. Takemori, A E

    1. Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.
      A E Takemori, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 121-124;

  2. Tani, M

    1. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
      K Chiba, K Kobayashi, K Manabe, M Tani, T Kamataki and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 52-59;

  3. Thomas, E A

    1. Kinetics of activation and in vivo muscarinic receptor binding of N-(2-bromoethyl)-4-piperidinyl diphenylacetate: an analog of 4-DAMP mustard.
      M T Griffin, E A Thomas and F J Ehlert
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 301-305;

  4. Tomoi, M

    1. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
      M Kadowaki, Y Nagakura, M Tomoi, J Mori and M Kohsaka
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 74-80;

  5. Tonello, C

    1. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
      E Nisoli, C Tonello, R Imhof, R Scherschlicht, M da Prada and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 97-105;

  6. Torphy, T J

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

  7. Tsai, C E

    1. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
      E A Johnson, C E Tsai, Y H Shahan and A J Azzaro
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 133-141;

U

  1. Uchida, M K

    1. Ca(++)-independent relaxation mediated by beta adrenoceptor in Ca(++)-independent contraction of uterine smooth muscle.
      T Ishine, Y Miyauchi and M K Uchida
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 367-373;

  2. Undem, B J

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

  3. Underwood, D C

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

W

  1. Wada, T

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  2. Wang, S Z

    1. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
      S Z Wang and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 237-243;

  3. Watanabe, A M

    1. Comparison of adenosine and muscarinic receptor-mediated effects on protein phosphatase inhibitor-1 activity in the heart.
      R C Gupta, J Neumann and A M Watanabe
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 16-22;

  4. Weinshilboum, R M

    1. Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.
      T A Glauser, A N Nelson, D E Zembower, J J Lipsky and R M Weinshilboum
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 23-32;

  5. Williams, K

    1. Effects of Agelenopsis aperta toxins on the N-methyl-D-aspartate receptor: polyamine-like and high-affinity antagonist actions.
      K Williams
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 231-236;

  6. Wilson, K T

    1. Sodium nitroprusside stimulates anion secretion and inhibits sodium chloride absorption in rat colon.
      K T Wilson, Y Xie, M W Musch and E B Chang
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 224-230;

  7. Wing, L Y

    1. Acetylpolyamines decrease blood pressure, [Ca++]i and isometric force of vascular smooth muscle.
      L Y Wing, C F Chan and M J Jiang
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 179-183;

  8. Winterhager, J M

    1. Electrogenic and electroneutral HCO3-secretion by guinea pig gallbladder epithelium: discriminatory abilities of Cl- channel blockers.
      K U Petersen, P Cormann, H J Macherey, G Sprakties and J M Winterhager
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 65-73;

  9. Wolsing, D H

    1. The mechanism for the rapid desensitization in bradykinin-stimulated inositol monophosphate production in NG108-15 cells involves interaction of a single receptor with multiple signaling pathways.
      D H Wolsing and J S Rosenbaum
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 253-261;

X

  1. Xie, Y

    1. Sodium nitroprusside stimulates anion secretion and inhibits sodium chloride absorption in rat colon.
      K T Wilson, Y Xie, M W Musch and E B Chang
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 224-230;

Z

  1. Zembower, D E

    1. Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.
      T A Glauser, A N Nelson, D E Zembower, J J Lipsky and R M Weinshilboum
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 23-32;

  2. Zenser, T V

    1. Phenylbutazone peroxidatic metabolism and conjugation.
      V M Lakshmi, T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 81-88;

  3. Zera, P

    1. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
      T A Deisher, H Narita, P Zera, R Ginsburg, M R Bristow, M E Billingham, M B Fowler and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 262-269;

  4. Zhang, X J

    1. Guinea pig ileitis is attenuated by the leumedin N-(fluorenyl-9- methoxycarbonyl)-leucine (NPC 15199).
      M J Miller, S Chotinaruemol, H Sadowska-Krowikca, X J Zhang, J A McIntyre and D A Clark
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 468-472;
Back to top

In this issue

Advertisement